Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Erythrocyte ouabain binding in patients receiving thyroxine.

A H Wilcox1, G E Levin

  • 1Department of Chemical Pathology, St George's Hospital Medical School, London, UK.

Clinical Endocrinology
|August 1, 1987
PubMed
Summary

Thyroid hormone replacement therapy may increase cellular thyroid hormone action, indicated by reduced erythrocyte sodium pump sites in treated women. This suggests potential over-treatment effects in some patients on thyroxine.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Routine transferrin saturation measurement in liver clinic patients increases detection of hereditary haemochromatosis.

Annals of clinical biochemistry·2003
Same author

Haemochromatosis gene mutations in idiopathic dilated cardiomyopathy.

Heart (British Cardiac Society)·2000
Same author

Secondary analysis of economic data: a review of cost-benefit studies of neonatal screening for phenylketonuria.

Journal of epidemiology and community health·1999
Same author

A systematic review of evidence for the appropriateness of neonatal screening programmes for inborn errors of metabolism.

Journal of public health medicine·1998
Same author

Newborn screening for inborn errors of metabolism: a systematic review.

Health technology assessment (Winchester, England)·1997
Same author

Thyroid antoantibodies and the response to thyrotropin releasing hormone in patients with subclinical hypothyroidism.

Journal of clinical pathology·1995

Area of Science:

  • Endocrinology
  • Cellular Biology
  • Thyroid Research

Background:

  • Thyroid hormone is crucial for cellular metabolism.
  • Hyperthyroidism is associated with reduced erythrocyte sodium pump sites.
  • The cellular effects of thyroxine replacement therapy require further investigation.

Purpose of the Study:

  • To investigate thyroid hormone action at the cellular level in women receiving thyroxine replacement therapy.
  • To compare cellular markers between thyroxine-treated patients, healthy individuals, and untreated thyrotoxic patients.

Main Methods:

  • Measured erythrocyte ouabain binding capacity to assess sodium pump sites.
  • Quantified plasma thyroxine (T4), free triiodothyronine (fT3), and thyroid-stimulating hormone (TSH).
  • Utilized high-sensitivity fluoroimmunoassay for TSH measurement.

Related Experiment Videos

Main Results:

  • Erythrocyte ouabain binding was significantly reduced in thyroxine-treated patients compared to healthy controls.
  • Reductions in binding were less pronounced than in untreated thyrotoxic patients.
  • Elevated plasma free T3 and undetectable TSH were observed in a subset of treated patients.

Conclusions:

  • Reduced erythrocyte ouabain binding suggests increased thyroid hormone action at the cellular level in some thyroxine-treated patients.
  • Findings indicate potential for over-replacement or increased cellular sensitivity.
  • Further research is warranted to understand the clinical implications of these cellular changes.